A detailed history of Pathstone Family Office, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pathstone Family Office, LLC holds 41,137 shares of EW stock, worth $3.04 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
41,137
Previous 26,072 57.78%
Holding current value
$3.04 Million
Previous $2.46 Million 15.86%
% of portfolio
0.02%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$69.28 - $93.38 $1.04 Million - $1.41 Million
15,065 Added 57.78%
41,137 $2.85 Million
Q2 2023

Jan 12, 2024

SELL
$81.41 - $94.33 $1.23 Million - $1.42 Million
-15,065 Reduced 36.62%
26,072 $2.46 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $105,914 - $122,723
1,301 Added 5.25%
26,072 $2.46 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $629,204 - $716,053
-8,473 Reduced 25.49%
24,771 $2.05 Million
Q4 2022

Oct 23, 2023

BUY
$68.3 - $87.44 $835,923 - $1.07 Million
12,239 Added 58.27%
33,244 $2.48 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $121,642 - $155,730
1,781 Added 5.66%
33,244 $2.48 Million
Q3 2022

Oct 23, 2023

BUY
$82.37 - $107.29 $313,088 - $407,809
3,801 Added 22.09%
21,005 $1.74 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $390,021 - $508,018
4,735 Added 17.72%
31,463 $2.65 Million
Q2 2022

Oct 23, 2023

SELL
$86.5 - $128.27 $767,082 - $1.14 Million
-8,868 Reduced 34.01%
17,204 $1.64 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $504,900 - $748,711
5,837 Added 27.94%
26,728 $2.54 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $1.34 Million - $1.69 Million
13,131 Added 169.21%
20,891 $2.53 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $264,861 - $325,393
2,490 Added 47.25%
7,760 $1.01 Million
Q3 2021

Nov 16, 2021

BUY
$102.91 - $122.75 $124,006 - $147,913
1,205 Added 29.64%
5,270 $598,000
Q2 2021

Aug 31, 2021

BUY
$83.84 - $104.76 $340,809 - $425,849
4,065 New
4,065 $421,000
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $42,565 - $49,052
-541 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $38,354 - $48,808
535 Added 8916.67%
541 $49,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $230 - $307
4 Added 200.0%
6 $0
Q1 2020

May 07, 2020

BUY
$52.41 - $81.0 $104 - $162
2 New
2 $377,000
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $724 - $837
-13 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $35,725 - $47,781
-746 Reduced 98.29%
13 $2,000
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $35,225 - $43,217
759 New
759 $116,000
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $36,290 - $38,830
-1,000 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
1,000
1,000 $118,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.